Table of Contents Chapter 1 Overview of Alzheimer's Disease Drug 1.1 Definition of Alzheimer's Disease Drug in This Report 1.2 Commercial Types of Alzheimer's Disease Drug 1.2.1 Donepezil 1.2.2 Memantine 1.2.3 Rivastigmine 1.3 Downstream Application of Alzheimer's Disease Drug 1.3.1 Hospital Pharmacy 1.3.2 Retail Pharmacy 1.3.3 Online Pharmacy 1.4 Development History of Alzheimer's Disease Drug 1.5 Market Status and Trend of Alzheimer's Disease Drug 2013-2023 1.5.1 Global Alzheimer's Disease Drug Market Status and Trend 2013-2023 1.5.2 Regional Alzheimer's Disease Drug Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Alzheimer's Disease Drug 2013-2017 2.2 Production Market of Alzheimer's Disease Drug by Regions 2.2.1 Production Volume of Alzheimer's Disease Drug by Regions 2.2.2 Production Value of Alzheimer's Disease Drug by Regions 2.3 Demand Market of Alzheimer's Disease Drug by Regions 2.4 Production and Demand Status of Alzheimer's Disease Drug by Regions 2.4.1 Production and Demand Status of Alzheimer's Disease Drug by Regions 2013-2017 2.4.2 Import and Export Status of Alzheimer's Disease Drug by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Alzheimer's Disease Drug by Types 3.2 Production Value of Alzheimer's Disease Drug by Types 3.3 Market Forecast of Alzheimer's Disease Drug by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Alzheimer's Disease Drug by Downstream Industry 4.2 Market Forecast of Alzheimer's Disease Drug by Downstream Industry Chapter 5 Market Driving Factor Analysis of Alzheimer's Disease Drug 5.1 Global Economy Situation and Trend Overview 5.2 Alzheimer's Disease Drug Downstream Industry Situation and Trend Overview Chapter 6 Alzheimer's Disease Drug Market Competition Status by Major Manufacturers 6.1 Production Volume of Alzheimer's Disease Drug by Major Manufacturers 6.2 Production Value of Alzheimer's Disease Drug by Major Manufacturers 6.3 Basic Information of Alzheimer's Disease Drug by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Alzheimer's Disease Drug Major Manufacturer 6.3.2 Employees and Revenue Level of Alzheimer's Disease Drug Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Alzheimer's Disease Drug Major Manufacturers Introduction and Market Data 7.1 Allergan 7.1.1 Company profile 7.1.2 Representative Alzheimer's Disease Drug Product 7.1.3 Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Allergan 7.2 Eisai 7.2.1 Company profile 7.2.2 Representative Alzheimer's Disease Drug Product 7.2.3 Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Eisai 7.3 Novartis 7.3.1 Company profile 7.3.2 Representative Alzheimer's Disease Drug Product 7.3.3 Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Novartis 7.4 Daiichi Sankyo 7.4.1 Company profile 7.4.2 Representative Alzheimer's Disease Drug Product 7.4.3 Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Daiichi Sankyo 7.5 Merz Pharma 7.5.1 Company profile 7.5.2 Representative Alzheimer's Disease Drug Product 7.5.3 Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Merz Pharma 7.6 Pfizer 7.6.1 Company profile 7.6.2 Representative Alzheimer's Disease Drug Product 7.6.3 Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Pfizer 7.7 Johnson & Johnson 7.7.1 Company profile 7.7.2 Representative Alzheimer's Disease Drug Product 7.7.3 Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Johnson & Johnson 7.8 Lundbeck 7.8.1 Company profile 7.8.2 Representative Alzheimer's Disease Drug Product 7.8.3 Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Lundbeck Chapter 8 Upstream and Downstream Market Analysis of Alzheimer's Disease Drug 8.1 Industry Chain of Alzheimer's Disease Drug 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Alzheimer's Disease Drug 9.1 Cost Structure Analysis of Alzheimer's Disease Drug 9.2 Raw Materials Cost Analysis of Alzheimer's Disease Drug 9.3 Labor Cost Analysis of Alzheimer's Disease Drug 9.4 Manufacturing Expenses Analysis of Alzheimer's Disease Drug Chapter 10 Marketing Status Analysis of Alzheimer's Disease Drug 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Donepezil Table Advantage and Disadvantage of Memantine Table Advantage and Disadvantage of Rivastigmine Table Production Volume of Alzheimer's Disease Drug by Regions 2013-2017 Table Production Value of Alzheimer's Disease Drug by Regions 2013-2017 Table Demand Volume of Alzheimer's Disease Drug by Regions 2013-2017 Table Production and Demand Status of Alzheimer's Disease Drug in Region One 2013-2017 Table Production and Demand Status of Alzheimer's Disease Drug in Region Two 2013-2017 Table Production and Demand Status of Alzheimer's Disease Drug in Region Three 2013-2017 Table Production and Demand Status of Alzheimer's Disease Drug in Region Four 2013-2017 Table Import Volume of Alzheimer's Disease Drug by Regions 2013-2017 Table Export Volume of Alzheimer's Disease Drug by Regions 2013-2017 Table Production Volume of Alzheimer's Disease Drug by Types 2013-2017 Table Production Value of Alzheimer's Disease Drug by Types 2013-2017 Table Production Volume Forecast of Alzheimer's Disease Drug by Types 2018-2023 Table Production Value Forecast of Alzheimer's Disease Drug by Types 2018-2023 Table Demand Volume of Alzheimer's Disease Drug by Downstream Industry 2013-2017 Table Demand Volume Forecast of Alzheimer's Disease Drug by Downstream Industry 2018-2023 Table Production Volume of Alzheimer's Disease Drug by Major Manufacturers 2013-2017 Table Production Value of Alzheimer's Disease Drug by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Alzheimer's Disease Drug Major Manufacturer Table Employees and Revenue Level of Alzheimer's Disease Drug Major Manufacturer Table Representative Alzheimer's Disease Drug Product One of Allergan Table Representative Alzheimer's Disease Drug Product Two of Allergan Table Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Allergan 2013-2017 Table Representative Alzheimer's Disease Drug Product One of Eisai Table Representative Alzheimer's Disease Drug Product Two of Eisai Table Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Eisai 2013-2017 Table Representative Alzheimer's Disease Drug Product One of Novartis Table Representative Alzheimer's Disease Drug Product Two of Novartis Table Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Novartis 2013-2017 Table Representative Alzheimer's Disease Drug Product One of Daiichi Sankyo Table Representative Alzheimer's Disease Drug Product Two of Daiichi Sankyo Table Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Daiichi Sankyo 2013-2017 Table Representative Alzheimer's Disease Drug Product One of Merz Pharma Table Representative Alzheimer's Disease Drug Product Two of Merz Pharma Table Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Merz Pharma 2013-2017 Table Representative Alzheimer's Disease Drug Product One of Pfizer Table Representative Alzheimer's Disease Drug Product Two of Pfizer Table Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Alzheimer's Disease Drug Product One of Johnson & Johnson Table Representative Alzheimer's Disease Drug Product Two of Johnson & Johnson Table Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Alzheimer's Disease Drug Product One of Lundbeck Table Representative Alzheimer's Disease Drug Product Two of Lundbeck Table Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin of Lundbeck 2013-2017